SCHEMBL23209237

SCHEMBL23209237

[CH2]CC(C)(N)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28511422 0.79
SCHEMBL6155261 0.71
SCHEMBL4756055 0.71 ALDH1A1 (0.32)
SCHEMBL277362 0.71
SCHEMBL15314520 0.71
SCHEMBL9003812 0.71
SCHEMBL589868 0.69
SCHEMBL589867 0.69
SCHEMBL8949982 0.69
SCHEMBL8370741 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174664-A1 BICYCLIC AMINES AS CDK2 INHIBITORS INCYTE CORPORATION 2024-05-30 US disclosed
US-11851426-B2 Bicyclic amines as CDK2 inhibitors INCYTE CORPORATION (US) 2023-12-26 US disclosed
US-20210107901-A1 BICYCLIC AMINES AS CDK2 INHIBITORS INCYTE CORPORATION 2021-04-15 US disclosed
WO-2021072232-A1 BICYCLIC AMINES AS CDK2 INHIBITORS INCYTE CORPORATION (US) 2021-04-15 WO disclosed
CN-1063442-C Aminothiazole derivatives, drug containing the same and intermediate in the production of the compounds ZERIA PHARM CO LTD (JP) 2001-03-21 CN disclosed
CN-1184471-A Aminothiazole derivatives, drug containing the same and intermediate in the production of the compounds ZERIA PHARM CO LTD (JP) 1998-06-10 CN disclosed